Related Experiment Video
Updated: Aug 12, 2026

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013
Strategies for accelerating osteogenesis through nanoparticle-based DNA/mitochondrial damage repair
Hye Jin Kim1, Hui Bang Cho1, Sujin Lee1
1Laboratory of Nano-regenerative Medicine, Department of Biomedical Science, College of Life Science, CHA University, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si, 13488, Republic of Korea.
New reagent GuaRD enhances gene therapy by protecting cells from damage caused by polyethyleneimine (PEI). GuaRD improves gene delivery efficiency and cell viability for applications like osteogenic differentiation.
Area of Science:
- Biomaterials Science
- Gene Therapy
- Stem Cell Biology
Background:
- Gene therapy efficiency relies on delivery systems; cationic polymers like polyethyleneimine (PEI) are common but can be cytotoxic.
- PEI-plasmid DNA polyplexes (PEI) show low efficiency in human mesenchymal stem cells (hMSCs) due to DNA damage and mitochondrial toxicity.
- Delivering osteogenic genes like RUNX2 is crucial for bone regeneration but hampered by delivery system limitations.
Purpose of the Study:
- To develop a novel reagent, GuaRD, for enhanced gene delivery of RUNX2 into hMSCs.
- To evaluate GuaRD's ability to mitigate PEI-induced cytotoxicity and improve cell stability.
- To assess GuaRD's impact on DNA repair, mitochondrial function, and osteogenic differentiation.
Main Methods:
- Development of GuaRD incorporating RS-1 nanoparticles for genomic/cellular stabilization.
- Transfection of hMSCs with pRUNX2 using either PEI or GuaRD.
- Assessment of DNA damage (double-strand breaks), mitochondrial integrity, reactive oxygen species (ROS) levels, and mitochondrial membrane potential.
- Quantification of DNA repair gene expression and osteogenic extracellular matrix (ECM) production.
Main Results:
- GuaRD significantly reduced DNA damage and mitochondrial damage in hMSCs compared to PEI.
- GuaRD treatment led to higher expression of DNA repair genes and improved mitochondrial stability (lower ROS, higher membrane potential).
- GuaRD enhanced osteogenic differentiation, evidenced by increased ECM expression and calcification, compared to PEI.
Conclusions:
- Reducing the cytotoxicity of gene delivery vectors like PEI is critical for effective gene therapy.
- GuaRD demonstrates potential as a superior reagent for gene delivery, enhancing cell viability and therapeutic outcomes.
- GuaRD offers a promising solution to overcome limitations in conventional gene therapy, particularly for bone regeneration applications.
More Related Videos
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
13:09Demonstration of the DNA Fiber Assay for Investigating DNA Damage and Repair Dynamics Induced by Nanoparticles
Published on: March 3, 2023